FI50831C - Menetelmä korkean tehoainepitoisuuden omaavan antasidipreparaatin valm istamiseksi. - Google Patents

Menetelmä korkean tehoainepitoisuuden omaavan antasidipreparaatin valm istamiseksi.

Info

Publication number
FI50831C
FI50831C FI691089A FI108969A FI50831C FI 50831 C FI50831 C FI 50831C FI 691089 A FI691089 A FI 691089A FI 108969 A FI108969 A FI 108969A FI 50831 C FI50831 C FI 50831C
Authority
FI
Finland
Prior art keywords
preparing
active ingredient
ingredient content
high active
antacid preparation
Prior art date
Application number
FI691089A
Other languages
English (en)
Swedish (sv)
Other versions
FI50831B (fi
Inventor
Garland Richard Brown
Original Assignee
Garland Richard Brown
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Garland Richard Brown filed Critical Garland Richard Brown
Application granted granted Critical
Publication of FI50831B publication Critical patent/FI50831B/fi
Publication of FI50831C publication Critical patent/FI50831C/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08Oxides; Hydroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10Carbonates; Bicarbonates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12Magnesium silicate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/245Bismuth; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI691089A 1968-04-18 1969-04-15 Menetelmä korkean tehoainepitoisuuden omaavan antasidipreparaatin valm istamiseksi. FI50831C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72217668A 1968-04-18 1968-04-18
US78572768A 1968-12-20 1968-12-20

Publications (2)

Publication Number Publication Date
FI50831B FI50831B (fi) 1976-04-30
FI50831C true FI50831C (fi) 1976-08-10

Family

ID=27110553

Family Applications (1)

Application Number Title Priority Date Filing Date
FI691089A FI50831C (fi) 1968-04-18 1969-04-15 Menetelmä korkean tehoainepitoisuuden omaavan antasidipreparaatin valm istamiseksi.

Country Status (15)

Country Link
JP (1) JPS4621672B1 (fi)
AU (1) AU438147B2 (fi)
BE (1) BE731695A (fi)
CA (1) CA959760A (fi)
CH (1) CH536114A (fi)
DE (1) DE1919802A1 (fi)
DK (1) DK127269B (fi)
ES (1) ES366173A1 (fi)
FI (1) FI50831C (fi)
FR (1) FR2007475A1 (fi)
GB (1) GB1269987A (fi)
IL (1) IL32020A (fi)
NL (1) NL6906087A (fi)
NO (1) NO129077B (fi)
SE (1) SE388356B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1401257A (en) * 1972-06-30 1975-07-16 Miles Lab Process for preparing a spray dried calcium carbonate composition
GB1601833A (en) * 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
SE7905972L (sv) * 1979-07-09 1981-01-10 Haessle Ab Forfarande for framstellning av magsyraneutraliserande medel, magsyraneutraliserande medel, samt metod for behandling av hyperaciditet och dermed relaterande sjukdomstillstand
AU590578B2 (en) * 1985-04-18 1989-11-09 Procter & Gamble Company, The Treatment of non-ulcer dyspepsia with bismuth salts
IT1215332B (it) * 1987-01-12 1990-02-08 Crinos Industria Farmaco Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica
DE3812378A1 (de) * 1988-04-14 1989-10-26 Theo Mertens Mobile erntegutmahl- und -mischvorrichtung
US4988679A (en) * 1989-01-03 1991-01-29 Leonard Chavkin Liquid sustained release composition
US4980175A (en) * 1989-01-03 1990-12-25 Leonard Chavkin Liquid orally administrable compositions based on edible oils
DE4305919A1 (de) * 1993-02-26 1994-09-01 Ruediger Potthoff Transportsilo für Kunststoff-Granulat
CN100400050C (zh) * 2002-02-04 2008-07-09 麦克尼尔-Ppc股份有限公司 用于治疗胃肠疾病的稳定药物组合物
WO2003074086A1 (fr) * 2002-03-04 2003-09-12 Medrx Co., Ltd. Matrice liquide a transfert de phase in vivo, et preparations liquides orales
US20030232092A1 (en) * 2002-06-14 2003-12-18 Hasenmayer Donald L. Liquid antacid compositions
RU2694530C2 (ru) 2014-04-29 2019-07-16 Дзе Проктер Энд Гэмбл Компани Способ изготовления жидких фармацевтических суспензий, содержащих висмут
MX2016013886A (es) 2014-04-29 2017-02-02 Procter & Gamble Suspensiones farmaceuticas liquidas que contienen bismuto.
CN114732828A (zh) * 2022-04-27 2022-07-12 广西南宁百会药业集团有限公司 一种铝碳酸镁混悬液及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE621147A (fi) *

Also Published As

Publication number Publication date
BE731695A (fi) 1969-10-20
AU5353969A (en) 1970-10-22
FR2007475A1 (fi) 1970-01-09
CA959760A (en) 1974-12-24
NL6906087A (fi) 1969-10-21
IL32020A (en) 1972-11-28
AU438147B2 (en) 1973-07-18
JPS4621672B1 (fi) 1971-06-19
GB1269987A (en) 1972-04-12
CH536114A (fr) 1973-04-30
ES366173A1 (es) 1971-04-01
FI50831B (fi) 1976-04-30
DK127269B (da) 1973-10-15
IL32020A0 (en) 1969-06-25
SE388356B (sv) 1976-10-04
NO129077B (fi) 1974-02-25
DE1919802A1 (de) 1969-11-06

Similar Documents

Publication Publication Date Title
NL149493B (nl) Werkwijze ter bereiding van een therapeutisch preparaat, gevormd preparaat, alsmede werkwijze ter bereiding van de daarbij toe te passen actieve verbindingen.
FI50831C (fi) Menetelmä korkean tehoainepitoisuuden omaavan antasidipreparaatin valm istamiseksi.
CH547798A (fr) Procede de preparation de nouvelles 5-azaspiro-(2,4)-heptane-4,6-diones.
FI51825C (fi) Menetelmä laktuloosijauheen valmistamiseksi.
FI45966C (fi) Menetelmä kokkiostaattisesti aktiivisten 4-hydroksi-6,7-dialkoksi-3-ka rboalkoksikinoliinien valmistamiseksi.
FI50766C (fi) Menetelmä vesipitoisen, sulfonamidia ja 2,4-diamino-5-substituoitu ben tsyylipyrimidiiniä sisältävän injektoitavan valmisteen valmistamiseksi .
BE771554A (fr) Ensileuse pour vegetaux, notamment pour le mais
FI48974C (fi) Menetelmä oraaliseen annostukseen sopivan, emäksistä dihydrodibentsats epiinia sisältävän farmaseuttisen valmisteen stabiloimiseksi.
FI44801C (fi) Menetelmä uusien, terapeuttisesti vaikuttavien, emäksisten eettereiden valmistamiseksi.
YU322569A (en) Process for preparing n-monosubstituted 2,4-dichloro-6-amino-s-triazines
FI50333C (fi) Tapa valmistaa terapeuttisesti aktiivista levo-1-n-butyyli-2',6'-pipek oloksylididiä.
FI51179C (fi) Menetelmä uusien hypoglykeemisesti vaikuttavien 1-(p-asyyliaminoalkyyl i-fenyylisulfonyyli)-2-imino-imidatsolidiinien valmistamiseksi.
SE445550B (sv) Forfarande for framstellning av fluormetyl-1,1,1,3,3,3-hexafluor-2-propyleter
FI48972C (fi) Menetelmä lääkeaineiden kiinteiden annostusyksiköiden valmistamiseksi.
BG17810A3 (bg) Метод за получаване на 1,3,4-тиадиазоли
BE758908R (fr) Procede de preparation de dimethyl-2, 2-hydroxy-3-
FI51349C (fi) Menetelmä terapeuttisesti vaikuttavien N-substituoitujen 6,7-bentsomor faanien valmistamiseksi.
FI45962C (fi) Menetelmä veren sokeripitoisuutta alentavien bentseenisulfonyylivirtsa -aineiden valmistamiseksi.
IL32202A0 (en) 1-alkoxy-or-aryloxy-1-thiono-3-halogen-or-3-alkyl phospholines,their preparation and use for combatting pests
FI44802C (fi) Menetelmä uusien analgeettisesti vaikuttavien, emäksisten eettereiden valmistamiseksi.
BG19178A3 (bg) Метод за получаване на 8-субституирани-5н-пироло-(2,1-с) 1,4 бензодиазепин-5-они
DK124679B (da) Analogifremgangsmåde til fremstilling af hjertevirksomme 4,5-epoxy-14β-hydroxybufa-20,22-dienolider.
FI49499C (fi) Mentelmä antimikrobisesti vaikuttavien sykloalkanokinolonijohdannaiste n valmistamiseksi
FI45324C (fi) Menetelmä 17beta-(1-alkoksi-sykloalkyyli)oksi-2alfa,3alfa-epitio-5alfa -androstaanien valmistamiseksi.
FI45756C (fi) Menetelmä kard-20(22)enolidien 3beta-tridesoksipyranosidien valmistami seksi.